{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:00:33Z","timestamp":1790996433066,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Non-profit Central Research Institute and Major Science","award":["2020-PT310-01"],"award-info":[{"award-number":["2020-PT310-01"]}]},{"name":"Technology Projects of Henan Province in 2020","award":["201300310300"],"award-info":[{"award-number":["201300310300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05679-6","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:33:23Z","timestamp":1729802003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High expression of PLA2G2A in fibroblasts plays a crucial role in the early progression of carotid atherosclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangfeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2315-0458","authenticated-orcid":false,"given":"Zongping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"5679_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokg\u00f6zo\u011flu L, Lewis EF. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56.","journal-title":"Nat Rev Dis Primers"},{"key":"5679_CR2","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","volume":"8","author":"P Song","year":"2020","unstructured":"Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI, Rudan I. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8:e721\u20139.","journal-title":"Lancet Glob Health"},{"key":"5679_CR3","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1161\/ATVBAHA.115.305234","volume":"35","author":"PJ Talmud","year":"2015","unstructured":"Talmud PJ, Holmes MV. Deciphering the causal role of sPLA2s and Lp-PLA2 in coronary heart disease. Arterioscler Thromb Vasc Biol. 2015;35:2281\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5679_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/01.ATV.0000257133.60884.44","volume":"27","author":"MA Bostrom","year":"2007","unstructured":"Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol. 2007;27:600\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5679_CR5","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.110.936393","volume":"122","author":"Z Mallat","year":"2010","unstructured":"Mallat Z, Lambeau G, Tedgui A. Lipoprotein-associated and secreted phospholipases A\u2082 in cardiovascular disease: roles as biological effectors and biomarkers. Circulation. 2010;122:2183\u2013200.","journal-title":"Circulation"},{"key":"5679_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/med.21597","volume":"40","author":"F Huang","year":"2020","unstructured":"Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: the story continues. Med Res Rev. 2020;40:79\u2013134.","journal-title":"Med Res Rev"},{"key":"5679_CR7","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","volume":"33","author":"RS Rosenson","year":"2012","unstructured":"Rosenson RS, Hurt-Camejo E. Phospholipase A2 enzymes and the risk of atherosclerosis. Eur Heart J. 2012;33:2899\u2013909.","journal-title":"Eur Heart J"},{"key":"5679_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22005","volume":"9","author":"S Sun","year":"2023","unstructured":"Sun S, Liu F, Fan F, Chen N, Pan X, Wei Z, Zhang Y. Exploring the mechanism of atherosclerosis and the intervention of traditional Chinese medicine combined with mesenchymal stem cells based on inflammatory targets. Heliyon. 2023;9: e22005.","journal-title":"Heliyon"},{"key":"5679_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.5114\/aoms.2020.98195","volume":"17","author":"Z Fras","year":"2021","unstructured":"Fras Z, Tr\u0161an J, Banach M. On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management. Arch Med Sci. 2021;17:954\u201364.","journal-title":"Arch Med Sci"},{"key":"5679_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/ATVBAHA.111.231548","volume":"31","author":"M Coen","year":"2011","unstructured":"Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol. 2011;31:2391\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5679_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/biom9090472","volume":"9","author":"S Singh","year":"2019","unstructured":"Singh S, Torzewski M. Fibroblasts and their pathological functions in the fibrosis of aortic valve sclerosis and atherosclerosis. Biomolecules. 2019;9:472.","journal-title":"Biomolecules"},{"key":"5679_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/01.STR.22.6.711","volume":"22","author":"NASCE Trial","year":"1991","unstructured":"Trial NASCE. Methods, patient characteristics, and progress. Stroke. 1991;22:711\u201320.","journal-title":"Stroke"},{"key":"5679_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","volume":"17","author":"R Saigusa","year":"2020","unstructured":"Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. 2020;17:387\u2013401.","journal-title":"Nat Rev Cardiol"},{"key":"5679_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/ATVBAHA.112.301174","volume":"33","author":"RB Schnabel","year":"2013","unstructured":"Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, Levy D, Keaney JF Jr, Wang TJ, et al. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol. 2013;33:1728\u201333.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5679_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.annepidem.2012.11.004","volume":"23","author":"OW Oluleye","year":"2013","unstructured":"Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol. 2013;23:66\u201373.","journal-title":"Ann Epidemiol"},{"key":"5679_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tibs.2009.08.003","volume":"35","author":"CN Birts","year":"2010","unstructured":"Birts CN, Barton CH, Wilton DC. Catalytic and non-catalytic functions of human IIA phospholipase A2. Trends Biochem Sci. 2010;35:28\u201335.","journal-title":"Trends Biochem Sci"},{"key":"5679_CR17","doi-asserted-by":"publisher","first-page":"33483","DOI":"10.1074\/jbc.M804628200","volume":"283","author":"H Sato","year":"2008","unstructured":"Sato H, Kato R, Isogai Y, Saka G, Ohtsuki M, Taketomi Y, Yamamoto K, Tsutsumi K, Yamada J, Masuda S, et al. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem. 2008;283:33483\u201397.","journal-title":"J Biol Chem"},{"key":"5679_CR18","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1093\/eurheartj\/ehs132","volume":"33","author":"L Lind","year":"2012","unstructured":"Lind L, Simon T, Johansson L, Kotti S, Hansen T, Machecourt J, Ninio E, Tedgui A, Danchin N, Ahlstr\u00f6m H, Mallat Z. Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality. Eur Heart J. 2012;33:2946\u201354.","journal-title":"Eur Heart J"},{"key":"5679_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/eurheartj\/ehq385","volume":"32","author":"BJ Arsenault","year":"2011","unstructured":"Arsenault BJ, Boekholdt SM, Kastelein JJ. Varespladib: targeting the inflammatory face of atherosclerosis. Eur Heart J. 2011;32:923\u20136.","journal-title":"Eur Heart J"},{"key":"5679_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692\u2013702.","journal-title":"Circ Res"},{"key":"5679_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fcvm.2018.00151","volume":"5","author":"M Li","year":"2018","unstructured":"Li M, Qian M, Kyler K, Xu J. Endothelial-vascular smooth muscle cells interactions in atherosclerosis. Front Cardiovasc Med. 2018;5:151.","journal-title":"Front Cardiovasc Med"},{"key":"5679_CR22","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.jacc.2018.08.2147","volume":"72","author":"KJ Moore","year":"2018","unstructured":"Moore KJ, Koplev S, Fisher EA, Tabas I, Bj\u00f6rkegren JLM, Doran AC, Kovacic JC. Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (Part 2). J Am Coll Cardiol. 2018;72:2181\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"5679_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajpath.2019.10.021","volume":"190","author":"MG Tinajero","year":"2020","unstructured":"Tinajero MG, Gotlieb AI. Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease. Am J Pathol. 2020;190:520\u201334.","journal-title":"Am J Pathol"},{"key":"5679_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCULATIONAHA.118.038362","volume":"140","author":"AS Kalluri","year":"2019","unstructured":"Kalluri AS, Vellarikkal SK, Edelman ER, Nguyen L, Subramanian A, Ellinor PT, Regev A, Kathiresan S, Gupta RM. Single-cell analysis of the normal mouse aorta reveals functionally distinct endothelial cell populations. Circulation. 2019;140:147\u201363.","journal-title":"Circulation"},{"key":"5679_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.athplu.2022.10.001","volume":"50","author":"Z Wang","year":"2022","unstructured":"Wang Z, Li G, Li M, Hu L, Hao Z, Li Q, Sun C. Periostin contributes to the adventitial remodeling of atherosclerosis by activating adventitial fibroblasts. Atheroscler Plus. 2022;50:57\u201364.","journal-title":"Atheroscler Plus"},{"key":"5679_CR26","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3390\/cells12242826","volume":"12","author":"E Lopes","year":"2023","unstructured":"Lopes E, Machado-Oliveira G, Sim\u00f5es CG, Ferreira IS, Ramos C, Ramalho J, Soares MIL, Melo T, Puertollano R, Marques ARA, Vieira OV. Cholesteryl hemiazelate present in cardiovascular disease patients causes lysosome dysfunction in murine fibroblasts. Cells. 2023;12:2826.","journal-title":"Cells"},{"key":"5679_CR27","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/ijms23063346","volume":"23","author":"S Jebari-Benslaiman","year":"2022","unstructured":"Jebari-Benslaiman S, Galicia-Garc\u00eda U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Mart\u00edn C. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23:3346.","journal-title":"Int J Mol Sci"},{"key":"5679_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01016-y","author":"P Maffia","year":"2024","unstructured":"Maffia P, Mauro C, Case A, Kemper C. Canonical and non-canonical roles of complement in atherosclerosis. Nat Rev Cardiol. 2024. https:\/\/doi.org\/10.1038\/s41569-024-01016-y.","journal-title":"Nat Rev Cardiol"},{"key":"5679_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.119.314845","volume":"124","author":"CB Xie","year":"2019","unstructured":"Xie CB, Qin L, Li G, Fang C, Kirkiles-Smith NC, Tellides G, Pober JS, Jane-Wit D. Complement membrane attack complexes assemble NLRP3 inflammasomes triggering IL-1 activation of IFN-\u03b3-primed human endothelium. Circ Res. 2019;124:1747\u201359.","journal-title":"Circ Res"},{"key":"5679_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","volume":"19","author":"EE West","year":"2023","unstructured":"West EE, Kemper C. Complosome\u2014the intracellular complement system. Nat Rev Nephrol. 2023;19:426\u201339.","journal-title":"Nat Rev Nephrol"},{"key":"5679_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf2489","volume":"6","author":"N Niyonzima","year":"2021","unstructured":"Niyonzima N, Rahman J, Kunz N, West EE, Freiwald T, Desai JV, Merle NS, Gidon A, Sporsheim B, Lionakis MS, et al. Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation. Sci Immunol. 2021;6: eabf2489.","journal-title":"Sci Immunol"},{"key":"5679_CR32","doi-asserted-by":"publisher","first-page":"108278","DOI":"10.1016\/j.intimp.2021.108278","volume":"101","author":"J Tao","year":"2021","unstructured":"Tao J, Zhao J, Qi XM, Wu YG. Complement-mediated M2\/M1 macrophage polarization may be involved in crescent formation in lupus nephritis. Int Immunopharmacol. 2021;101:108278.","journal-title":"Int Immunopharmacol"},{"key":"5679_CR33","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.immuni.2023.06.026","volume":"56","author":"MG Kiss","year":"2023","unstructured":"Kiss MG, Papac-Mili\u010devi\u0107 N, Porsch F, Tsiantoulas D, Hendrikx T, Takaoka M, Dinh HQ, Narzt MS, G\u00f6derle L, Ozsv\u00e1r-Kozma M, et al. Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis. Immunity. 2023;56:1809-1824.e1810.","journal-title":"Immunity"},{"key":"5679_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2010.02.005","volume":"211","author":"G Camejo","year":"2010","unstructured":"Camejo G. Lysophospholipids: effectors mediating the contribution of dyslipidemia to calcification associated with atherosclerosis. Atherosclerosis. 2010;211:36\u20137.","journal-title":"Atherosclerosis"},{"key":"5679_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/01.RES.86.6.707","volume":"86","author":"P Sartipy","year":"2000","unstructured":"Sartipy P, Johansen B, G\u00e2svik K, Hurt-Camejo E. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions. Circ Res. 2000;86:707\u201314.","journal-title":"Circ Res"},{"key":"5679_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"5679_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O\u2019Neill LA, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4\u207a T cells. Science. 2016;352: aad1210.","journal-title":"Science"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05679-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:33:54Z","timestamp":1729802034000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5679"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05679-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2018-KY-0067-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"967"}}